The specialized metabolism and trafficking of cellular subcompartments
Your first biology course probably defined eukaryotes in part as having a group of specialized organelles. These membrane-bound subcompartments of the eukaryotic cell are unique in many ways, especially their specialized biochemistry and metabolism.
The three sessions we have organized for Discover BMB will cover several topics focused on the novel biology and biochemistry of the mitochondria, peroxisome and chloroplast. These sessions will address current research on specific metabolic pathways, with important new insights into the protein structure and trafficking that support the integrity and function of these organelles.
Submit an abstract
Abstract submission begins Sept. 14. If you submit by Oct. 12, you'll get a decision by Nov. 1. The regular submission deadline is Nov. 30. See the categories.
These multidisciplinary talks will provide information not only on the specific biochemical functions of these organelles, but also on their integrative architecture and physiology. In the three sessions, new information will be integrated into general principles of organelle biogenesis and metabolic function.
Keywords: Mitochondria, chloroplast, peroxisome, metabolism, covalent modifications, organelle biogenesis, protein structure and trafficking.
Who should attend: Anyone interested in metabolism, organellar proteomes and the specialized biology of organelles.
Theme song: “The Cell” by Gojira, because it is such a high-energy song — mitochondria, chloroplasts ...
This session is powered by ATP.
Mitochondria, peroxisomes and chloroplast metabolism
Protein covalent modifications and chloroplast metabolism
Chair: Greg Moorhead
Greg Moorhead, University of Calgary
Glen Uhrig, University of Alberta
R. Paul Jarvis, University of Oxford
Paula Mulo, University of Turku
Peroxisome biogenesis/metabolism
Chair: Tom Rapoport
Francesca Di Cara, Dalhousie University
Brooke Gardner, University of California, Santa Barbara
Tom Rapoport, Harvard Medical School; Howard Hughes Medical Institute
Irfan Lodhi, Washington University in St. Louis
Mitochondria energetics/metabolism
Chair: Erin Goley
Pere Puigserver, Dana–Farber Cancer Institute; Harvard Medical School
Lena Pernas, Max Planck Institute for Biology of Ageing
Alexey Amunts, Stockholm University
Rebecca Voorhees, California Institute of Technology
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
Omega-3 fats linked to healthy aging and improved heart metabolism
Scientists from the University of Iowa find that a diet high in polyunsaturated fatty acids from fish oil increases cardiac triglyceride uptake and improves insulin sensitivity. Read more about this recent JLR study.
RA patient blood reveals joint innerworkings
Researchers in the Netherlands use mass spectrometry to compare the proteome of plasma and synovial fluid in rheumatoid arthritis patients and find a correlation. Read more about this recent paper in Molecular & Cellular Proteomics.
Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.
Before we’ve lost what we can’t rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.
Defeating deletions and duplications
Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader–Willi syndrome.
Using 'nature’s mistakes' as a window into Lafora disease
After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.